High Growth Tech Stocks To Explore This November 2024

In the wake of recent U.S. elections, global markets have experienced a significant rally, with major indices like the S&P 500 and Russell 2000 posting impressive gains due to investor optimism about potential economic growth and tax reforms. Amidst this backdrop, high-growth tech stocks remain an attractive area for exploration, as they often benefit from such macroeconomic conditions by leveraging innovation and scalability to drive future earnings potential.

Top 10 High Growth Tech Companies

Name	Revenue Growth	Earnings Growth	Growth Rating
Material Group	20.45%	24.01%	★★★★★★
Yggdrazil Group	24.66%	85.53%	★★★★★★
Scandion Oncology	40.71%	75.34%	★★★★★★
TG Therapeutics	34.66%	56.48%	★★★★★★
Pharma Mar	26.94%	56.39%	★★★★★★
Sarepta Therapeutics	23.89%	42.61%	★★★★★★
Alkami Technology	21.89%	98.60%	★★★★★★
Alnylam Pharmaceuticals	22.41%	70.53%	★★★★★★
Adveritas	57.98%	144.21%	★★★★★★
Travere Therapeutics	31.20%	72.26%	★★★★★★

Click here to see the full list of 1281 stocks from our High Growth Tech and AI Stocks screener.

We'll examine a selection from our screener results.

F-Secure Oyj (HLSE:FSECURE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: F-Secure Oyj is a cybersecurity company providing security solutions in Finland and internationally, with a market cap of €330.83 million.

Operations: F-Secure Oyj generates its revenue primarily from the Consumer Security segment, which accounts for €146.13 million. The company's focus on cybersecurity solutions supports its operations in both Finland and international markets.

F-Secure Oyj, navigating through a challenging tech landscape, reported a modest revenue increase to €109.22 million over nine months, up from €93.46 million in the previous year, reflecting a 3.5% growth rate which surpasses Finland's market average of 2%. Despite this growth, profit margins dipped to 14.3% from last year’s 21.4%, influenced by one-off gains of €6.1M that skewed earnings comparisons. Notably, the company's R&D commitment is robust, aligning with its forward-looking strategy as evidenced by an anticipated earnings growth of 15.5% annually—outpacing the Finnish market forecast of 14.4%. This focus on innovation could be pivotal for F-Secure as it adapts to evolving cybersecurity demands and integrates new technologies to stay competitive in a rapidly shifting sector.

• Click here to discover the nuances of F-Secure Oyj with our detailed analytical health report.

• Explore historical data to track F-Secure Oyj's performance over time in our Past section.

Lunit (KOSDAQ:A328130)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Lunit Inc. specializes in developing AI-based software solutions for cancer screening, diagnosis, and treatment, with a market cap of ₩1.15 billion.

Operations: With a market cap of approximately ₩1.15 trillion, the company generates revenue primarily from its healthcare software segment, amounting to ₩26.03 billion.

Lunit, a trailblazer in AI-driven healthcare solutions, recently showcased its innovations at the Society for Immunotherapy of Cancer meeting, underscoring its commitment to cutting-edge research and development. The company's R&D expenses have been pivotal in supporting a staggering revenue growth forecast of 51.8% per year, significantly outpacing the Korean market's average of 10.2%. Moreover, Lunit is poised for profitability with earnings expected to surge by 104.9% annually over the next three years—a testament to its robust pipeline and strategic market positioning despite current unprofitability and share price volatility.

• Navigate through the intricacies of Lunit with our comprehensive health report here.

• Assess Lunit's past performance with our detailed historical performance reports.

Brockhaus Technologies (XTRA:BKHT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Brockhaus Technologies AG is a private equity firm with a market capitalization of €250.74 million.

Operations: Brockhaus Technologies AG focuses on two primary revenue segments: Security Technologies, generating €37.03 million, and Financial Technologies, contributing €174.59 million. The company operates as a private equity firm with a market capitalization of €250.74 million.

Brockhaus Technologies, navigating through a challenging tech landscape, has demonstrated resilience with a forecasted revenue growth of 16.8% annually, surpassing Germany's average of 5.5%. This growth is coupled with an ambitious trajectory toward profitability within three years, underscored by an impressive expected earnings surge of 93% per year. Recent engagements at high-profile investment conferences and solid financial guidance for the upcoming years reflect the company's strategic focus on scaling operations and enhancing shareholder value. With R&D expenses strategically aligned to fuel these advancements, Brockhaus is positioning itself as a dynamic contender in the tech arena despite current unprofitability and competitive pressures.

• Click here and access our complete health analysis report to understand the dynamics of Brockhaus Technologies.

• Review our historical performance report to gain insights into Brockhaus Technologies''s past performance.

Summing It All Up

• Embark on your investment journey to our 1281 High Growth Tech and AI Stocks selection here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com